Mineralys Therapeutics MLYS
NASDAQ MLYS
$23.72 -1.41 (-5.61%)
At close: Oct 1, 2026 · 4:00 PM EDT

Mineralys Therapeutics (MLYS) Other Non-Current Assets (2022 - 2026)

Updated

Mineralys Therapeutics' Other Non-Current Assets was $2.02 million in Q2 2026, up 367.4% from $433,000 a year earlier and up 462.2% from the prior quarter.

Analysis

Mineralys Therapeutics (MLYS) Other Non-Current Assets (2022 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Assets at Mineralys Therapeutics came in at $382,000, down 23.4% from FY2024.

  • Other Non-Current Assets shows a three-year compound annual growth rate of -38.4% (FY2022 to FY2025).
  • In earlier years, Other Non-Current Assets was $499,000 in FY2024 (+878.4%), $51,000 in FY2023 (-96.9%) and $1.63 million in FY2022.
  • The Q2 2026 figure marks the highest quarterly Other Non-Current Assets in data going back to Q4 2022.
  • Compared with a year earlier, Other Non-Current Assets was higher in four of the last eight quarters, with growth averaging 241.6%.
  • The best year-over-year quarter for Other Non-Current Assets over five years was Q4 2024 (growth of 878.4%); the worst was Q4 2023 (a decline of 96.9%).
  • Per Business Quant data, MLYS's Other Non-Current Assets in the three quarters before Q2 2026 was $360,000 (Q1 2026), $382,000 (Q4 2025) and $144,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Mineralys Therapeutics 2.22 Bn 2.22 Bn - 2.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.02 Mn
Mar 31, 2026 360,000.00
Dec 31, 2025 382,000.00
Sep 30, 2025 144,000.00
Jun 30, 2025 433,000.00
Mar 31, 2025 397,000.00
Dec 31, 2024 499,000.00
Sep 30, 2024 452,000.00
Jun 30, 2024 449,000.00
Mar 31, 2024 379,000.00
Dec 31, 2023 51,000.00
Sep 30, 2023 51,000.00
Jun 30, 2023 51,000.00
Mar 31, 2023 39,000.00
Dec 31, 2022 1.63 Mn
API Access

Mineralys Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=MLYS&period=max&api_key=YOUR_API_KEY